Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Clarivate recently released the list of Highly Cited Researchers for 2022.

The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.

New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.

Silicone wristbands could be more convenient option for collecting exposure data.

Focused research studies of advanced algorithms and materials are setting the stage for the next generation of quantum computers.

Customized molecular tools identify specific microbial functions that are key to healthy people and environments.

PNNL provided ultra-low measurements of argon-39 to date groundwater as part of a collaborative study of the aquifer in California’s San Joaquin Valley. PNNL is one of only a few laboratories worldwide with this capability.

A new article reviews bio-orthogonal click chemistry reagents that can be used as probes to label metabolic pathways in plants and microbes.

Ultra-trace radiation detection technique sets new global standard for measuring the nearly immeasurable.

Scientists at PNNL have contributed much of the nuclear science that underlies an international monitoring system designed to detect nuclear explosions worldwide. The system detects radioxenon anywhere on the planet.